Two friends from Essex have smashed their £10,000 fundraising target as they gear up to take on the London Marathon in ...

Purdue University scientists have identified the Supinoxin molecule as a possible new therapy for small cell lung cancer.

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Romvimza is a medicine called a kinase inhibitor that is used to treat tenosynovial giant cell tumor (TGCT ... substrates, breast cancer resistance protein (BCRP) substrates, or organic cation ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

The diagnosis: small-cell neuroendocrine carcinoma. “They (doctors ... Brian’s insurer is Meritain Health, which is a subsidiary of industry giant Aetna. After Meritain rejected the initial ...

BioNTech shows off lung cancer survival data behind phase 3 push ... After bagging a positive phase 3 trial in tenosynovial giant cell tumors, Merck KGaA has expanded its licensing deal with ...

This stops bone cells being broken down and strengthens the bone. You might have denosumab if you have a type of primary bone cancer called giant cell tumour of the bone. You might have it if you are ...

The diagnosis: small-cell neuroendocrine carcinoma. “They (doctors ... which is a subsidiary of industry giant Aetna. After Meritain rejected the initial immunotherapy drug, Imfinzi, Brian ...

The pharmaceutical giant reported sales of $21.89 billion ... Darzalex sales rose 20.3% to $3.24 billion. The company’s cancer cell therapy, Carvykti, generated sales of $369 million.

a blood cancer. Having completed chemotherapy, he went into remission and returned to playing soccer full-time. However, ...